Suite of solutions delivers monitoring for all, says Deltex at EBPOM

Mid January saw Deltex supporting the EBPOM (Evidence-based perioperative medicine) organisation at its first meeting of 2018. Entitled “Current Initiatives, Research and the Role of Hemodynamic Monitoring” the event was attended by a sell-out audience of 80 anaesthetists and associated care providers.

The general theme from the speakers was that patient care and safety would be improved with broader adoption of haemodynamic monitoring. Interestingly this coincides with the news from the United States that a major teaching hospital has said standard operating procedure will be to include oesophageal Doppler monitoring (ODM) as part of its enhanced recovery protocol across colorectal and urological surgery. The hospital’s own 150 patient evaluation supported the claim that length of patient stay could be reduced by routine use of cardiac output monitoring using the Deltex system.

Until recently a limitation to widespread adoption of haemodynamic monitoring using ODM was its restriction to anaesthetised or critical care patients (“awake” patients often can’t tolerate an indwelling probe in their oesophagus). Deltex has solved the problem by adding best-in-class alternative monitoring technologies to its offering. The ODM+ platform, incorporating TrueVue software now features a suite of options including Pulse Pressure Waveform Analysis (PPWA) and High Definition Impedance Cardiography (HD-ICG), both non-invasive monitoring solutions. This upgrade for ODM+ gives the clinician the choice of a variety of monitoring modes, based on perceived patient risk.

Identifying earlier when intervention is needed saves lives and improves outcomes. The data supports this, and now a suite of options delivers clinicians the real world possibility of monitoring for all.

Terminus Road | Chichester | PO19 8TX | United Kingdom

  • Enquiries: +44 1243 774837
  • Email:
  • Deltex App:


Registered in England & Wales Company No: 1691369